Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | TXNRD1 | Q16881 | 6/20 | 0.51 |
| ▸ | TXNRD3 | Q86VQ6 | 6/20 | 0.51 |
| ▸ | TXNRD2 | Q9NNW7 | 6/20 | 0.51 |
| ▸ | FYN | P06241 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gamma-Cyclodextrin SCHEMBL3819072 | 0.91 | ALDH1A1 (0.74) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL441667 | 0.91 | ALDH1A1 (0.74) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL5507793 | 0.89 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Alfadex SCHEMBL18705306 | 0.89 | ALDH1A1 (0.77) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| SCHEMBL14479710 | 0.83 | ALDH1A1 (0.67) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL5165343 | 0.80 | ALDH1A1 (0.74) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL28281939 | 0.80 | ALDH1A1 (0.87) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Gamma-Cyclodextrin SCHEMBL28276059 | 0.80 | ALDH1A1 (0.87) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL8746198 | 0.78 | ALDH1A1 (0.83) | ALDH1A1TSHRLMNATDP1TXNRD1 | |
| Betadex SCHEMBL23188251 | 0.78 | ALDH1A1 (1.00) | ALDH1A1TSHRLMNATDP1TXNRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1133274-B1 | SKIN DEODORIZING AND SANITIZING COMPOSITIONS | PROCTER & GAMBLE (US) | 2008-10-01 | — | — | EP | claimed |
| US-6656456-B2 | Skin deodorizing formulation: an effective amount of odor controlling agent, a thickener, water and optional perfume, emollient and antimicrobial preservative | THE PROCTER & GAMBLE COMPANY | 2003-12-02 | — | — | US | claimed |
| US-20020176879-A1 | SKIN DEODORIZING COMPOSITIONS | PROCTER & GAMBLE COMPANY, THE | 2002-11-28 | — | — | US | claimed |
| US-6344218-B1 | GEL COMPRISING ODOR CONTROLLING AGENT TO PROVIDE ODOR CONTROL BENEFIT, SANITIZING AGENT, THICKENER, EMOLLIENT, PERFUME, WATER | THE PROCTER & GAMBLE COMPANY | 2002-02-05 | — | — | US | claimed |
| EP-1133274-A1 | SKIN DEODORIZING AND SANITIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-19 | — | — | EP | claimed |
| EP-1131044-A1 | SKIN DEODORIZING AND SANITIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-12 | — | — | EP | claimed |
| EP-1131045-A1 | SKIN DEODORIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-12 | — | — | EP | claimed |
| WO-2000030600-A1 | SKIN DEODORIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-02 | — | — | WO | claimed |
| WO-2000030599-A1 | SKIN DEODORIZING AND SANITIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-02 | — | — | WO | claimed |
| WO-2000030601-A1 | SKIN DEODORIZING AND SANITIZING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-06-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020176879-A1 | SKIN DEODORIZING COMPOSITIONS | OR10J3, DSG1, OR51E2 | ALDH1A1 348/4885TSHR 4600/4885LMNA 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.